Logo
Apparel & Fashion

Description

Our advanced API development program delivers high-purity active pharmaceutical ingredients designed for the global pharmaceutical industry. We are developing specialized compounds including anti-neoplastic agents for cancer treatment, mydriatic and cycloplegic substances for ophthalmic applications, and atracurium besylate BP/USP for anesthesia protocols. Each API undergoes stringent development processes to ensure full compliance with international standards including BP and USP monographs. Our commitment to quality begins at molecular level development and extends through every development stage, ensuring reliable performance in final drug formulations. These developing APIs represent our dedication to addressing critical healthcare needs through innovative pharmaceutical solutions that meet the highest industry standards.

These APIs serve diverse pharmaceutical sectors including oncology, ophthalmology, anesthesiology, and critical care medicine. Anti-neoplastic APIs support compr...
Our advanced API development program delivers high-purity active pharmaceutical ingredients designed for the global pharmaceutical industry. We are developing specialized compounds including anti-neoplastic agents for cancer treatment, mydriatic and cycloplegic substances for ophthalmic applications, and atracurium besylate BP/USP for anesthesia protocols. Each API undergoes stringent development processes to ensure full compliance with international standards including BP and USP monographs. Our commitment to quality begins at molecular level development and extends through every development stage, ensuring reliable performance in final drug formulations. These developing APIs represent our dedication to addressing critical healthcare needs through innovative pharmaceutical solutions that meet the highest industry standards.

These APIs serve diverse pharmaceutical sectors including oncology, ophthalmology, anesthesiology, and critical care medicine. Anti-neoplastic APIs support comprehensive cancer treatment regimens in hospital and clinical settings worldwide. Mydriatic and cycloplegic compounds enable eye care professionals to conduct thorough diagnostic examinations and precise surgical procedures with confidence. Atracurium besylate meets specific requirements in operating theaters and intensive care units for controlled muscle relaxation during medical procedures. Pharmaceutical manufacturers utilize these APIs to develop specialized medications that address specific therapeutic requirements across multiple healthcare segments. The applications extend across generic drug manufacturing, specialty pharmaceuticals, and hospital compounding facilities serving global healthcare needs.

Our API development program delivers exceptional value through reliable quality, consistent performance characteristics, and comprehensive technical support. Pharmaceutical companies benefit from partnering with a development team committed to stringent quality control and regulatory compliance throughout the development process. We understand that API reliability directly impacts drug efficacy and patient safety outcomes, which drives our implementation of rigorous testing protocols during development. Our technical team provides extensive support to help clients successfully integrate these APIs into their formulations and manufacturing processes. The development framework includes stability studies, detailed impurity profiling, and complete documentation support to facilitate regulatory submissions and approvals.

Key Features:
- Developing anti-neoplastic APIs including specialized cancer treatment compounds
- Mydriatic and cycloplegic compounds for ophthalmic diagnostic applications
- Atracurium besylate BP/USP meeting neuromuscular blockade requirements
- Full compliance with BP and USP pharmacopeia standards throughout development
- Comprehensive quality control protocols during development phase

Benefits:
- High-purity active ingredients ensuring reliable drug formulation performance
- Consistent quality and batch-to-batch reliability for manufacturing confidence
- Compliance with international pharmacopeia standards for global acceptance
- Technical support throughout development and formulation integration
- Rigorous testing protocols ensuring safety and efficacy in final medications

Specifications

Additional Information
Country of OriginIndia

Application

Our developing API portfolio addresses critical healthcare needs with precision-engineered active ingredients. Anti-neoplastic compounds support advanced cancer treatment protocols, while specialized mydriatic and cycloplegic agents enable essential ophthalmic diagnostic and surgical procedures. These pharmaceutical intermediates maintain consistent purity and reliability throughout formulation development across multiple therapeutic classes. Atracurium besylate BP/USP meets rigorous neuromuscular blockade requirements for anesthesia and critical care applications. Each API undergoes comprehensive development to ensure full compliance with international pharmacopeia standards. Pharmaceutical manufacturers can confidently develop specialized medications with assured quality and batch-to-batch consistency for clinical use. - Cancer treatment medications utilizing anti-neoplastic APIs for chemotherapy formulations - Ophthalmic solutions for pupil dilation during comprehensive eye examinations - Diagnostic procedures requiring precise cycloplegic agents for accurate vision assessment - Anesthesia protocols using atracurium besylate for controlled neuromuscular blockade - Specialty pharmaceutical manufacturing for hospital and clinical therapeutic applications

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Cash on Delivery (COD, if applicable)

Company Profile

Khandelwal Laboratories Pvt Ltd, Maharashtra
TruBasic
IndiaMaharashtra, India
Health & Personal Care•Manufacturer•Retailer•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Pharmaceutical APIs Anti Neoplastic Mydriatic Cycloplegic Atracurium Besylate

Premium pharmaceutical APIs including anti-neoplastic, mydriatic, cycloplegic, and atracurium besylate BP/USP for reliable drug manufacturing. High-purity active ingredients ensure consistent quality and performance in therapeutic applications.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Khandelwal Laboratories Pvt Ltd
TruBasic
IndiaMaharashtra, India
Health & Personal CareManufacturer

More Products From Supplier